2024-515850-26-00CompletedPhase 2
PET-DOPA Metabolic Detection and Characterization of Untreated Brain Metastases of Bronchial, Breast and Melanoma Cancer
PET-DOPA Metabolic Detection and Characterization of Untreated Brain Metastases of Bronchial, Breast and Melanoma Cancer (DOPACER)
Source: EU CTIS (euclinicaltrials.eu) · Last updated 10 Dec 2024
Brief summary (registry, in English)
To define the sensitivity of PET-DOPA for the detection of newly diagnosed untreated brain metastases (breast, lung, melanoma) on MRI measuring at least 5 mm in diameter
- Status (registry)
- Completed
- Phase (registry)
- Phase 2
- Study type
- Interventional
- Enrollment
- 52 (actual)
- First submitted
- 27 Jun 2024
- Start date
- 3 Dec 2021
- Lead sponsor
- Institut De Cancerologie De L Ouest
- Diseases
- Lung cancer, Melanoma
- EU CT number
- 2024-515850-26-00
- EudraCT number
- 2021-001017-37
What you commit to
- Study type: Interventional · Phase 2
- Participants enrolled: 52
- 4 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Who cannot take part
Copied verbatim from EU CTIS (euclinicaltrials.eu) and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previous brain surgery for brain metastasis or glial tumor
- Systemic therapy (chemotherapy, targeted therapy, immunotherapy) modified in the 6 weeks preceding the PET-DOPA scan,
- New anti-tumor treatment (excluding corticosteroids) started between the discovery of CD and the performance of the PET-DOPA scan
Other illness
- History of cerebral irradiation
- Other concomitant cancer, or history of cancer in the 5 years preceding the patient's inclusion in the protocol other than basal or squamous cell carcinoma
Other
- Pregnant, likely to be pregnant or breastfeeding
Who the study is looking for
- Histologically proven primary cancer (non-small cell lung, breast or melanoma)
- Presence of brain metastasis(s) visualized on MRI, with at least 1 measuring more than 5 mm
- Age ≥ 18 years
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (4)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Institut de Cancerologie de L'Ouest | Angers | France | Completed |
| Centre Hospitalier Universitaire D'Angers | Angers | France | Completed |
| Hôpital NOVO | Pontoise | France | Completed |
| Institut De Cancerologie De L Ouest | Saint-Herblain Cedex | France | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.